Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells (2013)
- Authors:
- USP affiliated authors: MORALES, ANDRESSA GOIS - IB ; HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidades: IB; FFCLRP; FMRP
- DOI: 10.1007/s10238-011-0166-1
- Subjects: ANTINEOPLÁSICOS (ESTUDO IN VITRO); APOPTOSE; NEOPLASIAS DO COLO UTERINO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical and Experimental Medicine
- ISSN: 1591-8890
- Volume/Número/Paginação/Ano: v. 13, n. 1, p. 75-80, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PEZUK, Julia Alejandra et al. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells. Clinical and Experimental Medicine, v. 13, n. 1, p. 75-80, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10238-011-0166-1. Acesso em: 23 abr. 2024. -
APA
Pezuk, J. A., Brassesco, M. S., Oliveira, J. C. de, Morales, A. G., Montaldi, A. P., Sakamoto-Hojo, E. T., et al. (2013). Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells. Clinical and Experimental Medicine, 13( 1), 75-80. doi:10.1007/s10238-011-0166-1 -
NLM
Pezuk JA, Brassesco MS, Oliveira JC de, Morales AG, Montaldi AP, Sakamoto-Hojo ET, Scrideli CA, Tone LG. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 1): 75-80.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1007/s10238-011-0166-1 -
Vancouver
Pezuk JA, Brassesco MS, Oliveira JC de, Morales AG, Montaldi AP, Sakamoto-Hojo ET, Scrideli CA, Tone LG. Antiproliferative in vitro effects of BI 2536-mediated PLK1 imhibition on cervical adenocarcinoma cells [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 1): 75-80.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1007/s10238-011-0166-1 - BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity
- MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells
- Cytogenetic instability in childhood acute lymphoblastic leukemia survivors
- Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation
- Effects of polo-like kinase 1 inhibition on glioblastoma cell lines
- PLK1 expression and Bl 2536 effects in childhood acute lymphoblastic leukemia
- Low MIR-196B and high MIR-708 expression are associated with T-cell childhood acute lymphoblastic leukemia
- Characterization of LGALS3 (galectin-3) as a player in DNA damage response
- Silencing of checkpoint mitotic genes inhibits the proliferation and clonogenicity in pediatric glioblastoma cell line
- Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells
Informações sobre o DOI: 10.1007/s10238-011-0166-1 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
